InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by KASINGER JAMES R., Conseiller Juridique Général et Secrétaire. Director active across 1 companies, notably CRISPR Therapeutics AG. In total, 7 reports have been published. The latest transaction was filed on 2 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations7 total
2,834 shares
Common Shares
SEC:0001209191-22-018609:0·
13,333 shares
Common Shares
SEC:0001209191-21-068453·
13,333 shares
Common Shares
SEC:0001209191-21-068453:0·
€88,3417,342 shares@ €12.0323100.0% of flow
Common Shares
SEC:0001209191-21-068014·
€88,3417,342 shares@ €12.03230.0019% mcap50.0% of flow
Common Shares
SEC:0001209191-21-068014:0·
10,000 shares
Common Shares
SEC:0001209191-21-056093·
10,000 shares
Common Shares
SEC:0001209191-21-056093:0·
7 of 7 declarations
About KASINGER JAMES R.
James R. Kasinger is the General Counsel and Secretary at CRISPR Therapeutics AG. He is responsible for managing the company's legal affairs. With expertise in business law, he plays a key role in protecting the company's legal interests. James R. Kasinger is committed to supporting the company's mission while ensuring legal compliance.
